Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease

Abstract

Transgelin may be a potential target in the development of irreversible CHD-PAH through inducing PASMC phenotype change, proliferation, migration and reducing cell apoptosis.